Chapel Hill, NC – (May 13, 2014) – Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced that Dr. Jack Modell has joined its team as their senior medical officer, bringing 20 years of experience in clinical research, teaching, and patient care in academic medicine, and an additional 10 years of experience in clinical drug development (phase II-IV), medical affairs, medical governance, drug safety, and management within the pharmaceutical industry.
A board-certified psychiatrist, Jack has led a distinguished academic career. As a tenured professor, he authored over 50 peer-reviewed publications spanning numerous therapeutic and scientific areas, including addiction medicine, anesthesiology, psychiatry, neurology, and nuclear medicine. Prior to joining Rho, Jack was employed at GlaxoSmithKline where he helped lead several successful development programs in the neurosciences. He was responsible for both drugs in development and marketed products as a vice president of neurosciences, and as a vice president in medical governance he helped to harmonize research policies and standards across the organization.
"Jack's distinguished academic career and his leadership in neurosciences at a well-respected North Carolina-based pharmaceutical company are just a few of the reasons we brought him on board at Rho," said Russ Helms, Ph.D., chief executive officer for Rho. "We look forward to Jack's contribution to our management team and to utilizing his expertise to continue Rho's 30-year track record of providing an exceptional customer experience to both our commercial and federal clients," added Dr. Helms.
As Rho's senior medical officer, Jack's responsibilities include providing medical, clinical, and scientific strategic and operational expertise to all areas of the company to ensure the scientific integrity of clinical trials and the safety and welfare of subjects in these trials. His expertise will help to maximize study efficiency, validity, signal detection, and regulatory approvability.
About Rho
Rho, a privately-held, contract research organization (CRO) located in Chapel Hill, NC, provides a full range of clinical research services across the entire drug development process. For 30 years, Rho has been a trusted partner to some of the industry's leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, our innovative technologies, and our therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience. For more information, please visit www.rhoworld.com and follow us on Twitter.